| ACO | asthma–COPD overlap |
| ACT | asthma control test |
| ATS | American Thoracic Society |
| BA | bronchial asthma |
| CAT | COPD assessment test |
| COPD | chronic obstructive pulmonary disease |
| CRP | C-reactive protein |
| DLCO | diffusing capacity of the lung for carbon monoxide |
| d–ROMs | derivatives–reactive oxygen metabolites |
| ERS | European Respiratory Society |
| FeNO | fractional exhaled nitric oxide |
| FEV1 | forced expiratory volume in 1 s |
| FVC | forced vital capacity |
| GINA | Global Initiative for Asthma |
| GOLD | Global Initiative for Chronic Obstructive Lung Disease |
| HRCT | high-resolution computed tomography |
| ICS | inhaled corticosteroids |
| IgE | immunoglobulin E |
| IL | interleukin |
| JRS | Japanese Respiratory Society |
| LAA | low attenuation area |
| LAMA | long-acting muscarinic antagonists |
| LABA | long-acting beta2-agonists |
| OCS | oral corticosteroids |
| ROC | receiver operating characteristic |
| ROS | reactive oxygen species |
| SAA | serum amyloid A |
| SGRQ | St. George’s Respiratory Questionnaire |
| TNF-α | tumor necrosis factor alpha |
| WBC | white blood cell |